Results 151 to 160 of about 132,663 (245)

Optimal Cutoff Size of Large Borrmann Type III Gastric Cancer: Is 8 cm Accurate in Predicting Survival and Incidence of Peritoneal Metastasis?

Annals of Gastroenterological Surgery, EarlyView.
ABSTRACT Background Large type III gastric cancer (GC) ≥ 8 cm has conventionally been categorized with type IV GC in Japan, leading to alternative treatment strategies such as neoadjuvant chemotherapy and staging laparoscopy (SL). However, whether 8 cm is the correct cutoff remains unclear.
Yutaka Sugita, Manabu Ohashi, Naoki Miyazaki, Motonari Ri, Rie Makuuchi, Tomoyuki Irino, Masaru Hayami, Takeshi Sano, Souya Nunobe   +8 more
wiley   +1 more source

Effects of radiotherapy, chemotherapy, and chemoradiotherapy on survival outcomes in patients with gallbladder carcinoma: a real population-based study. [PDF]

Transl Cancer Res
Liu F, Qin Y, Li L, Jiao B.
europepmc   +1 more source

Essential Updates 2023/2024: Minimally Invasive Surgery for Biliary Tract Cancer

Annals of Gastroenterological Surgery, EarlyView.
ABSTRACT Minimally invasive surgery (MIS) for biliary tract cancer (BTC) has gained traction with advancements in laparoscopic and robotic techniques. However, its oncological impact remains uncertain. This review highlights key studies from 2023 and 2024 on MIS for BTC, including distal bile duct, hilar bile duct, gallbladder, and intrahepatic bile ...
Osamu Itano, Takuya Minagawa
wiley   +1 more source

Liver metastases from oropharyngeal squamous cell carcinoma: a rare case report. [PDF]

J Surg Case Rep
Solis-Pazmino D, Baldin R, Guarçoni M, Bertinatto R, Maldonado P, Cedeno A, Ma R, Coral RP, Solis-Pazmino P.   +8 more
europepmc   +1 more source

Hypofractionation in adjuvant breast radiotherapy

The Breast, 2011
openaire   +3 more sources

Adjuvant radiotherapy: no survival benefit? [PDF]

Nature Reviews Urology, 2009
openaire   +2 more sources

Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy

Aggregate, EarlyView.
Nanomaterial (NM)‐induced toxicity can be strategically repurposed for cancer therapy. This review summarizes the mechanism by which NMs selectively activate specific cellular processes to regulate cell fate independently. We also discussed how NMs‐induced biological responses can be leveraged as therapeutic strategies for cancer treatment.
Liting Wang, Hao Fu, Jiangtao Lin, Meng Zhao, Chuanrong Chen, Hongze Liao, Yourong Duan   +6 more
wiley   +1 more source

The Impact of Salvage Radiotherapy in Recurrent Endometrial Cancer: A Review Focusing on Early-Stage, Endometrial Cancer Locoregional Relapses. [PDF]

Life (Basel)
Maragkoudakis E, Panoskaltsis T, Pavlakis K, Grenzelia M, Kavoura E, Papageorgiou G, Georgakopoulos I, Kougioumtzopoulou A, Kypraiou E, Trogkanis N, Maragkoudakis E, Kouloulias V, Zygogianni A.   +12 more
europepmc   +1 more source

Mycosis Fungoides, Sézary Syndrome, and Cutaneous B‐Cell Lymphomas: 2025 Update on Diagnosis, Risk‐Stratification, and Management

American Journal of Hematology, EarlyView.
ABSTRACT Disease Overview Primary cutaneous lymphomas are a rare and heterogeneous group of extranodal lymphomas that require the integration of clinical and histopathologic data for classification and treatment. Diagnosis Diagnosis and disease classification is based on histopathologic review and immunohistochemical staining of an appropriate skin ...
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox   +2 more
wiley   +1 more source

Wound Healing Complication in Radio-Treated Limb Soft Tissue Sarcoma Patients: A Single Referral Centre Experience. [PDF]

Int Wound J
Dal Pos S, Mazza M, Gianesini CM, Cavallin F, Del Fiore P, Tropea S, Parisi A, Ghirelli A, Buzzaccarini MS, Scarzello G, Mocellin S.   +10 more
europepmc   +1 more source